Long term treatment with betaine in methylenetetrahydrofolate reductase deficiency

Archives of Disease in Childhood

Volumn 74, Issue 3, 1996, Pages 239-241

  Ronge, Eric ^a   Kjellman, Bengt ^a  

^a CENTRAL HOSPITAL   (Sweden)

Author keywords

5,10 Methylenetetrahydrofolate reductase deficiency; 5 Methyltetrahydrofolate; Betaine; Long term treatment

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BETAINE; FOLIC ACID; HOMOCYSTEINE; METHIONINE;

ARTICLE; CASE REPORT; DISEASE COURSE; ENZYME DEFICIENCY; FEMALE; HUMAN; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0029865546     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.74.3.239     Document Type: Article

References (11)

1. Mudd SH, Uhlendorf BW, Freeman JM, Finkelstein JD, Shih VE. Homocystinuria associated with decreased methylenetetrahydrofolate reductase activity. Biochem Biophys Res Commun 1972; 46: 905-12.
2. Erbe RW. Folates and pterins: nutritional, pharmacological and physiological aspects. In: Blakley RL, Whitehead VM, eds. Inborn errors of folate metabolism, vol 3. New York: John Wiley, 1986: 413-65.
3. Wendel U, Bremer HJ. Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Eur J Pediatr 1984; 142: 147-50.
4. Holme E, Kjellman B, Ronge E. Betaine for treatment of homocystinuria caused by methylenetetrahydrofolate reductase deficiency. Arch Dis Child 1989; 64: 1061-4.
5. Brandt NJ, Christensen E, Skovby F, Djernes B. Treatment of methylene-tetrahydrofolate reductase from the neonatal period. Amersfoort, The Netherlands: The Society for Study of Inborn Errors of Metabolism 1986: 23.
6. Surtees R, Leonard J, Austin S. Association of demyelination with deficiency of cerebrospinal fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway. Lancet 1991; ii: 1550-4.
7. Gamstorp I, Kjellman B, Palmgren B. Diencephalic syndromes of infancy. J Pediatr 1967; 70: 383-90.
8. Kjellman B, Gamstorp I, Brun A, Ockerman P-A, Palmgren B. Mannidosis: a clinical and histopathologic study. J Pediatr 1969; 75: 366-73.
9. Brattström L, Hardebo J-E, Hultberg B. Moderate homocysteinemia - a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 1984; 15: 1012-6.
10. Takenaka T. Effect of folic acid for treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Rinsho Shinkeigaku 1993; 33: 140-5.
11. Surtees R, Heales S, Bowron A. Association of cerebrospinal fluid deficiency of 5-methyltetrahydrofolate, but not S-adenosyl methionine, with reduced concentrations of the acid metabolites of 5-hydroxytryptamine and dopamine. Clin Sci 1994; 86: 697-702.